Matinas BioPharma Holdings, Inc. — All Filings
546 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B3
424B5
8-A12B
8-K
8-K/A
ARS
CERTNYS
CORRESP
CT ORDER
D
DEF 14A
DEL AM
DRS
DRS/A
EFFECT
NT 10-K
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SP 15D2
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-003445 | Jan 23, 2026 | Jan 22, 2026 |
| 8-K | 8-K | 0001493152-25-027529 | Dec 12, 2025 | — |
| 8-K | 8-K | 0001493152-25-024691 | Nov 21, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-004953 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-021506 | Nov 10, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001213900-25-091622 | Sep 25, 2025 | — |
| SCHEDULE 13G | — | 0000921895-25-002331 | Aug 19, 2025 | — |
| 8-K | 8-K | 0001641172-25-024520 | Aug 18, 2025 | Aug 15, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-003632 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-024014 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001641172-25-022445 | Aug 6, 2025 | — |
| 8-K | 8-K | 0001641172-25-016064 | Jun 23, 2025 | — |
| S-8 | S-8 | 0001641172-25-016134 | Jun 23, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-011026 | May 15, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0001641172-25-009754 | May 12, 2025 | — |
| 4 | — | 0001641172-25-008424 | May 2, 2025 | Apr 30, 2025 |
| 4 | — | 0001641172-25-008426 | May 2, 2025 | Apr 30, 2025 |
| 4 | — | 0001641172-25-008425 | May 2, 2025 | Apr 30, 2025 |
| PRE 14A | PRE 14A | 0001641172-25-008421 | May 2, 2025 | — |
| 4 | — | 0001641172-25-008427 | May 2, 2025 | Apr 30, 2025 |
| 4 | — | 0001641172-25-008423 | May 2, 2025 | Apr 30, 2025 |
| 8-K | CURRENT REPORT | 0001641172-25-008417 | May 2, 2025 | Apr 30, 2025 |
| ARS | — | 0001641172-25-006696 | Apr 29, 2025 | Dec 31, 2024 |
| EFFECT | — | 9999999995-25-001290 | Apr 29, 2025 | — |
| 424B3 | — | 0001641172-25-006688 | Apr 29, 2025 | — |
| CORRESP | — | 0001641172-25-006376 | Apr 28, 2025 | — |
| UPLOAD | — | 0000000000-25-004450 | Apr 28, 2025 | — |
| S-3 | — | 0001641172-25-005741 | Apr 22, 2025 | — |
| 10-K | — | 0001641172-25-004882 | Apr 15, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | — | 0001477932-25-002598 | Apr 10, 2025 | — |
| 3 | FORM 3 | 0001477932-25-002606 | Apr 10, 2025 | Feb 13, 2025 |
| 4/A | FORM 4 A | 0001477932-25-002583 | Apr 10, 2025 | Apr 8, 2025 |
| 4/A | FORM 4 A | 0001477932-25-002594 | Apr 10, 2025 | Apr 8, 2025 |
| SCHEDULE 13D/A | — | 0001477932-25-002577 | Apr 10, 2025 | — |
| 4/A | FORM 4 A | 0001477932-25-002580 | Apr 10, 2025 | Apr 8, 2025 |
| 8-K | — | 0001641172-25-003271 | Apr 8, 2025 | — |
| 8-K | — | 0001641172-25-002818 | Apr 4, 2025 | — |
| NT 10-K | — | 0001641172-25-001849 | Mar 31, 2025 | Dec 31, 2024 |
| 3 | — | 0001493152-25-010653 | Mar 17, 2025 | Mar 11, 2025 |
| 3 | — | 0001493152-25-010654 | Mar 17, 2025 | Mar 11, 2025 |
| 8-K | — | 0001493152-25-010416 | Mar 14, 2025 | Mar 13, 2025 |
| 8-K | — | 0001493152-25-009775 | Mar 11, 2025 | — |
| 3 | FORM 3 | 0001477932-25-001559 | Mar 7, 2025 | Feb 13, 2025 |
| DEF 14A | — | 0001493152-25-008921 | Mar 3, 2025 | — |
| 3 | FORM 3 | 0001477932-25-001352 | Feb 28, 2025 | Feb 13, 2025 |
| 3 | FORM 3 | 0001477932-25-001257 | Feb 25, 2025 | Feb 13, 2025 |
| SCHEDULE 13D | — | 0001477932-25-001179 | Feb 21, 2025 | — |
| SCHEDULE 13D | — | 0001477932-25-001180 | Feb 21, 2025 | — |
| PRE 14A | — | 0001493152-25-007921 | Feb 21, 2025 | — |
| D | — | 0001493152-25-007569 | Feb 19, 2025 | — |